MedPath

Mobile Health Intervention to Improve Exercise in Pediatric PH

Not Applicable
Not yet recruiting
Conditions
Pulmonary Arterial Hypertension
Registration Number
NCT06549452
Lead Sponsor
Vanderbilt University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion Criteria:<br><br> - Adolescents between ages 13-19 years.<br><br> - Diagnosed with idiopathic, heritable, or associated (connective tissue disease,<br> drugs, or toxins) pulmonary arterial hypertension (PAH), or PAH due to simple<br> congenital heart disease (i.e. atrial septal defect).<br><br> - WHO functional class I-III<br><br> - Stable PAH-specific medication regimen for three months prior to enrollment.<br> Subjects with only a single diuretic adjustment in the prior three months will be<br> included. Adjustments in IV prostacyclin for side effect management are allowed.<br><br> - Forced vital capacity >65% predicted with no or minimal interstitial lung disease<br> based on reviews of imaging studies by PI and medical monitor.<br><br>Exclusion Criteria:<br><br> - Prohibited from normal activity due to wheelchair bound status, bed bound status,<br> reliance on a cane/walker, activity-limiting angina, activity-limiting<br> osteoarthritis, or other condition that limits activity.<br><br> - Pregnancy<br><br> - Diagnosis of PAH etiology other than idiopathic, heritable, or associated.<br><br> - Functional class IV heart failure<br><br> - Requirement of > 2 diuretic adjustment in the prior three months.<br><br> - Preferred form of activity is not measured by an activity tracker (swimming, yoga,<br> ice skating, stair master, or activities on wheels such as bicycling or<br> rollerblading).<br><br> - Involved in any other investigational intervention.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in average daily step count from baseline to 12 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath